PCOS: the evidence-based guide

TL;DR

• PCOS is not really about cysts - ovarian morphology is one possible feature, not the core problem.
• Diagnosis is two of three under the Rotterdam criteria: irregular or absent ovulation, signs of elevated androgens, and polycystic ovary morphology, with other causes excluded.
• Insulin resistance is the engine for a large proportion of women - elevated insulin pushes the ovaries to produce more androgens, which disrupts ovulation.
• That mechanism also raises long-term risk of type 2 diabetes and cardiometabolic disease.
• Lifestyle work is genuinely first-line because it targets insulin sensitivity directly, improving cycles and symptoms rather than just weight.
• Medical options are matched to goals: metformin, GLP-1 medications, combined hormonal contraceptives, or fertility-specific treatment.

Educational content, not medical advice. No doses or protocols appear. PCOS diagnosis and treatment require a physician.

---

PCOS affects a large share of women of reproductive age, yet it's frequently missed, mislabeled, or reduced to "just a fertility issue." It's actually a whole-body hormonal and metabolic condition with real implications for cycles, fertility, metabolism, mood, and long-term health. The good news: it's manageable, and the most effective approaches target the mechanism underneath it - often insulin resistance. Here's the honest overview.

What PCOS actually is

Despite the name, PCOS isn't really about "cysts" - the ovarian appearance is one possible feature, not the core problem. It's a syndrome, diagnosed (by the widely used Rotterdam criteria) when at least two of three are present:

• Irregular or absent ovulation (irregular, long, or missing cycles)
• Signs of elevated androgens - clinically (acne, excess hair growth, scalp hair thinning) or on bloodwork
• Polycystic ovary morphology on ultrasound

Because it's a "two of three" diagnosis, PCOS looks different from woman to woman - which is part of why it's so often missed. Other causes have to be ruled out first, so it's a diagnosis made by a clinician, not a self-label.

The engine underneath: insulin resistance

For a large proportion of women with PCOS, insulin resistance is central. Elevated insulin drives the ovaries to produce more androgens, which disrupts ovulation and drives many of the visible symptoms - and it also raises long-term risks for type 2 diabetes and cardiometabolic disease. This is the key insight, because it explains why interventions that improve insulin sensitivity tend to help across the board - cycles, symptoms, and metabolic health together.

What actually helps

Management is individual and depends on goals (symptom relief, fertility, metabolic health), but the evidence-based pillars are:

• Lifestyle foundations - because insulin sensitivity is central, resistance training, activity, sleep, and nutrition (guided individually, not by crash dieting) are genuinely first-line, and they improve cycles and symptoms, not just weight.
• Metformin - an insulin-sensitizing medication long used in PCOS to improve metabolic parameters and, for some, ovulation.
• GLP-1 medications - increasingly relevant where weight and metabolic health are involved, given PCOS's insulin-resistance core; a physician-guided option covered in the GLP-1 guide. (As always, if weight loss is part of the plan, muscle preservation matters.)
• Combined hormonal contraceptives - often used to regulate cycles and manage androgen-related symptoms (acne, hair) when fertility isn't the immediate goal.
• Targeted symptom care - for acne, hair changes, and mood, alongside the metabolic work.
• Fertility support - when pregnancy is the goal, specific ovulation-focused treatments exist and are managed by a specialist.

The unifying theme: treat the metabolic engine, and many downstream symptoms improve together.

The bottom line - and where to start

PCOS is common, real, and manageable - but it's often mishandled because the insulin-resistance core gets missed and the condition gets reduced to fertility alone. The evidence-based path is to treat the mechanism: build the lifestyle foundations that improve insulin sensitivity, add medical options (metformin, GLP-1s, hormonal or fertility treatments) where they fit your goals, and monitor the long-term metabolic risks that PCOS carries. That starts with proper diagnosis and metabolic assessment - not guesswork or a supplement bought on a symptom.

Explore it with verified supply. Every Vivre Labs lot is independently tested and the certificate of analysis is published, so you know exactly what is in the vial.

Frequently asked questions

What are the main signs of PCOS? Irregular or missing periods, signs of elevated androgens (acne, excess hair growth, scalp thinning), and polycystic ovaries on ultrasound - a diagnosis is made when at least two of these three are present and other causes are ruled out. Many women also have insulin resistance.

Is PCOS caused by insulin resistance? For a large proportion of women, insulin resistance is a central driver - elevated insulin pushes the ovaries to produce more androgens, disrupting ovulation and driving symptoms. That's why improving insulin sensitivity (through lifestyle, and sometimes metformin or GLP-1s) tends to help broadly.

Can GLP-1s help with PCOS? They're increasingly used where weight and metabolic health are part of the picture, given PCOS's insulin-resistance core, as a physician-guided option. As with any weight loss, preserving muscle matters. Whether a GLP-1 fits depends on your individual goals and health, assessed by a clinician.

Related reading

• HRT in 2026 · Menopause, metabolism & weight · The complete GLP-1 guide · GLP-1s for women & PCOS · What an AMH test tells you - why AMH often runs high in PCOS
• Part of The Complete Guide to Women's Hormonal Health

---

Educational content, not medical advice. PCOS requires diagnosis and management by a qualified clinician; other conditions must be excluded. Medications discussed are prescription medicines. This article gives no dosing or calorie/macro targets. Claims for the Malaysian market are subject to MAB requirements.

References

• PCOS diagnosis: Rotterdam criteria (2 of 3: oligo/anovulation, hyperandrogenism, polycystic ovarian morphology; exclusion of other causes). · Insulin resistance as a central driver; hyperinsulinemia → ovarian androgen production; elevated long-term risk of type 2 diabetes and cardiometabolic disease. · Management: lifestyle/insulin sensitivity, metformin, GLP-1 receptor agonists where indicated, combined hormonal contraceptives for cycle/androgen symptoms, fertility-specific treatments.